DP
David P Meeker sold $5.1M of RYTM stock
David P Meeker, President and CEO of Rhythm Pharmaceuticals, Inc. (RYTM), sold 50,000 shares of RYTM stock worth $5.1M, per an SEC Form 4 filed Sep 14, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Sep 14, 2026.
RYTM has moved +14.0% since the trade date, from $102.44 to $116.80 (Nov 19, 2026 close).
- Traded
- Sep 14, 2026
- Disclosed
- Sep 14, 2026
- Filing delay
- 0 days
- Price since
- +14.0%
- Role
- President and CEO
- Source
- SEC Form 4